UPDATE | March 6, 2023

Pfizer inks $183M contract manufacturing deal with Samsung Biologics

  • MAIL

Pfizer inks $183M contract manufacturing deal with Samsung Biologics
 

Two years after burgeoning CDMO powerhouse Samsung Biologics signed on to manufacture COVID-19 vaccines for Moderna, the Korean company has made a deal with the world’s other leading mRNA vaccine producer, Pfizer. 

 

Read more

Pfizer inks $183M contract manufacturing deal with Samsung Biologics 

 

Two years after burgeoning CDMO powerhouse Samsung Biologics signed on to manufacture COVID-19 vaccines for Moderna, the Korean company has made a deal with the world’s other leading mRNA vaccine producer, Pfizer. 

 

Read more 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required